Paylocity Holding Corporation Share Price Target ‘$193.96’, now 14.2% Upside Potential

DirectorsTalk Interviews

Paylocity Holding Corporation which can be found using ticker (PCTY) now have 19 market analysts covering the stock. The analyst consensus now points to a rating of ‘buy’. The range between the high target price and low target price is between $250.00 and $155.00 and has a mean share price target at $193.96. (at the time of writing). Given that the stocks previous close was at $169.82 this indicates there is a potential upside of 14.2%. Also worth taking note is the 50 day moving average now sits at $165.56 and the 200 day moving average is $171.21. The market cap for the company is 9.27B. The stock price is currently at: $164.19 USD

The potential market cap would be $10,582,544,294 based on the market consensus.

The company has a dividend yield of 0.89%. Other points of data to note are a P/E ratio of 47.87, revenue per share of $24.12 and a 3.37% return on assets.

Paylocity Holding Corporation is a cloud-based provider of payroll and human capital management (HCM) software solutions. The Company’s services are provided in a Software-as-a-Service (SaaS) delivery model utilizing its cloud-based platform. The Company’s product suite comprises of payroll, human capital management, workforce management, talent management, benefits, employee experiences, implementation and training services, insights and recommendations and tax and regulatory services, that delivers a unified platform. Its cloud-based platform provides a unified suite of modules using a multi-tenant architecture. Its platform provides self-service functionality for employees and managers combined with integration across all its solutions. The Company’s platform also offers an automated data integration with third-party partner systems, which includes 401(k), benefits and insurance provider systems.

Share on:
Find more news, interviews, share price & company profile here for:

    Drax confirms final HEIT offer and plans to let scheme lapse

    Drax Group plc updates on its acquisition offer for HEIT, confirming a final bid of 88p per share while announcing potential changes to the acquisition timeline.

    Poolbeg Pharma raises £4.7m through Placing and Subscription

    Poolbeg Pharma has successfully raised £4.715 million to fund innovative clinical trials, including POLB 001 and an oral GLP-1 programme, addressing critical medical needs.

    DynaResource technical report validates 250000oz of gold and significant upside

    DynaResource, Inc. unveils a promising S-K 1300 Technical Report for the San Jose de Gracia mine, revealing 250,000 gold ounces in Initial Mineral Reserves.

    Vodafone Group Plc launches €500m Share Buyback

    Vodafone Group Plc announces a €500 million share repurchase program aimed at reducing share capital, set to commence on May 20, 2025.

    Warpaint London posts 2024 Annual Report and AGM Notice

    Warpaint London plc (LON:W7L) announces the release of its 2024 Annual Report and details for the upcoming AGM on June 17, 2025.

    Poolbeg Pharma launches £4.1m fundraising

    Poolbeg Pharma plc (LON:POLB) announces a conditional fundraising aimed at raising £4.1 million to drive innovative pharmaceutical developments and address unmet medical needs.

      Search

      Search